A number of strong letters came into The Nation
in response to my article on Obama, progressives, and healthcare. They will be published in a forthcoming issue, along with my rejoinder. Readers of this blog might be interested in an advanced look.
In “
A Spoonful of Sugar” [Feb. 13] his review of Paul Starr’s book on healthcare
reform, Bernard Avishai says that I have been “hammering away” in support of
policies insurance plans could use to control costs. Not so. I have never
championed such marginal remedies, because I believe the main causes of the US
system’s excessive costs are elsewhere—in its commercialized investor-owned
organization and in its incentives to maximize income. For-profit private
insurers generate huge unnecessary costs, as does the fee-for-service system.
I advocate replacement of private insurers by a public tax-supported single
payer, and replacement of fee-for-service by prepaid universal entitlement to
comprehensive care in a not-for-profit system. The elimination of billing and
collecting avoids excessive overhead costs and prevents the rampant fraud
afflicting the present insurance-based system. But it also requires providers
to accept global payment, reimburse physicians largely with salaries and
support multispecialty groups in which primary care doctors collaborate closely
with specialists. Organized care like this outperforms private practice and is
expanding.
Avishai and Starr dismiss the possibility of such transformation, but a rapidly growing
number of physicians are choosing employment in multispecialty groups, and
physicians’ support of major reform is gaining. Furthermore, employees insured
at work now realize how badly the system is broken when they must contribute
more to their medical costs and receive fewer benefits. They, too, may soon be
ready for major change.
The Affordable Care Act took a step toward reform by expanding and improving
coverage, but it still relies on private insurance and fee-for-service, and it
will therefore not control rising costs. We should not give up on the further
reforms so urgently needed.
Arnold S. Relman, MD professor emeritus of medicine and social medicine,
Harvard Medical School; former editor, The New England Journal of Medicine
Bernard Avishai’s strident defense of the Patent Protection and Affordable Care Act
would have been far more persuasive if he had analyzed the law on its merits
rather than treating it as a test of President Obama’s statesmanship. The law
has positive features, but its main achievement was to take a health insurance
industry which was in danger of pricing itself out of the market and bail it
out with $44 billion of our tax dollars—money that could have gone to pay for
medical care. In the process, a $12 billion industry’s stranglehold on our
healthcare system has tightened.
Something closely resembling the PPACA has been on the books in Massachusetts for six
years, thanks to the efforts of a Republican governor and the nation’s leading
conservative think-tank. Today nearly everyone in Massachusetts has some kind
of health insurance, but a recent study published in the New England Journal of
Medicine reveals that there has been no real change in the incidence of people
winding up in bankruptcy court because they can’t pay their medical bills.
According to the Kaiser Family Foundation, high deductible insurance policies,
which were virtually unknown five years ago have become commonplace, a trend
likely to intensify once PPACA’s mandatory coverage requirement kicks in in
2014.
I defy Avishai (or Paul Starr, whose book he admiringly reviews) to show up for
one of those bankruptcy court hearings and tell some poor fish, who has lost
his home or his life savings to pay for a premature baby or a few rounds of
chemotherapy his insurance wouldn’t cover, that he should be grateful because
“Obamacare was healthcare reform’s best—and last—shot.”
This country is capable of much better, and its people have a right to expect much
more. But we won’t get it if we allow temporizing politicians (and their
apologists) to write our ticket for us. FDR embraced the reforms of the New
Deal because people took to the streets and demanded it of him. We need to do
the same for Obama, instead of wasting our time and energy making excuses for
him with tortured polemics.
Peter Shapiro
Oregon Single Payer Campaign
Bernard Avishai takes aim at progressive critics of Obama’s healthcare reform bill,
portraying them as hopelessly naïve and out of touch with political reality.
But intimate acquaintance with medical reality drove the criticism from us and
our 18,000 colleagues in Physicians for a National Health Program who advocate
single-payer reform. As doctors, we’re too cognizant that the reform will leave
23 million of our patients uninsured and thousands dying each year from lack of
coverage; do nothing for our insured patients with coverage so skimpy that
serious illness would lead to bankruptcy; strip tens of billions from safety
net hospitals; and let medical costs continue to skyrocket, leaving Medicare
and public workers’ coverage vulnerable to savage cuts. Whatever its political
merits, the bill is a failure in medical terms.
If
anything’s naïve, it’s Avishai’s faith in cost savings from generalizing the
Mayo Clinic model (Mayo, which shuns uninsured and Medicaid patients—and
Medicare at some of its clinics—was dropped from two big insurers’ networks
because of its high costs) and from standardized and computerized billing. He
seems unaware that computer firms have been promising paperwork savings for
forty-six years (see the 1966 video posted at youtube.com/watch?v=t-aiKlIc6uk).
Yet the savings haven’t materialized, and there’s not an iota of evidence they
will. He also seems unaware that hospital billing has been standardized and computerized for years (they all use the same ICD coding system, the UB82 billing form). As our studies in The New
England Journal of Medicine have shown, single-payer reform could eliminate
about $400 billion wasted annually on insurance overhead and billing paperwork;
the reforms Avishai lauds will save bupkis.
Obama’s
reform, closely patterned on a Heritage Foundation proposal, will deliver
billions to insurance and drug firms, and paltry benefit to the American
people. Yet Avishai would have progressives hold their tongues. Should we also
hold our tongues about the administration’s missteps on civil liberties,
education “reform” or the environment?
David
U. Himmelstein,
Steffie
Woolhandler, M.D., M.P.H.
Bernard Avishai’s review has so many errancies, it’s challenging to begin addressing them here. One recent vignette helps illustrate some of his oversights. An
insurance company from Senator Lieberman’s state denied a follow-up scan for a patient on whom I had operated (successfully) for metastatic cancer.
This scan is the “standard of care” noted in national guidelines. The company’s
medical director (a physician) eventually approved it, after I fought their insidious, nonmedical bureaucracy. But the insurer only did so after I wrote a two-page heavily footnoted letter, detailing how their “decision” was essentially malpractice.
If only 5 percent of physicians who have appropriate procedures blocked by
insurers fail to appeal, those unspent funds become revenue for the insurer. Avishai asks, “Wouldn’t a public plan enjoy critical savings…if it didn’t have to pay dividends to shareholders or engage in marketing?” He then leaves this fundamental question unaddressed. He goes into a lengthy discussion of claims “processing.” He does not address the fact that dividends and profits provide zero “value-added,” for patients. No other industrialized democracy finances healthcare primarily via for-profit corporations. There is no policy reason for us to have this system (or other countries might use it also, no?).
Profit and dividends are the real reason “why healthcare in America eats up almost
double what it does in other Western democracies,” to quote his misdirected phrase. He mentions “Switzerland’s mixed, complicated system, also based on private sector insurers” but fails to note that those insurers are nonprofit!
Physician activists for single-payer were arrested when they protested their exclusion from discussions with President Obama and Senator Baucus. The “not-monolithic
Democratic Party” didn’t deign to even include this broadly supported position in the conversation, much less in negotiations. This goes unmentioned by Avishai, along with too much else.
William A. Wood, MD
Georgetown Delaware
***
Bernard Avishai replies:
I did not argue in my review against single-payer. I stated that an Ontario-like system—where the government is the single insurer, the patient pool cannot be
cherry-picked, and procedures are performed by multispecialty groups and hospitals on a fixed budget—is best for controlling costs. Paul Starr believes this. So does President Obama, for that matter. For the record, I introduced Dr. Relman to my colleagues at
Harvard Business Review in the
early 90s, where he subsequently
published a defense of single-payer. Much of the criticism in these letters is misplaced, though the tone of some reveals my real point.
It was: that single-payer had no chance of passing—none—because (as Starr’s
history shows) Americans do not live in Ontario; that all major Democratic
candidates supposed it was a non-starter during the primaries and Obama knew
where his votes were (and weren’t) early in the spring of 2009; that the Act he,
Pelosi, and Reed got through the Congress nevertheless does tremendous good,
covering 30 million people who would otherwise not be covered; that some of the
claims against the Act from progressive voices—e.g., the need for a
Medicare-like administration to gain savings from claims processing, or the
indispensability of a “public option”—were exaggerated if not wrong; that the
intemperance of these claims—specifically, that Obama sold out to insurance
companies—played into Tea Party demagogy about his being a feckless captive of
Eastern elites who foist their self-serving experiments on, you know, ordinary
people; that if Obama is not reelected, it will be owing to the defection of “independents”—presumably
such ordinary people who, like those who rallied to the Cambridge police in the
Gates case, didn’t need much proof that a Harvard-trained African-American was
not to be trusted; that progressives should know enough not to make the great
the enemy of the good (that FDR compromised with Jim Crow, for God’s sake, to get
Social Security and other good things passed).
Dr.
Relman reiterates his support for single-payer insurance—also for what he takes
to be its counterpart, salaried doctors, collaborative practice, and “global
payment” (i.e., physician groups working from fixed budgets). Fair enough. But to
appreciate Obama’s achievement, as Starr painstakingly shows, the dysfunctions
of American healthcare need to be further unbundled. For my part, I praised
Relman not for his insurance cure, single-payer, but for his diagnosis of the medical
industry as a whole, namely, the incentives to game “fee-for-service.” Relman
has indeed hammered away at the point (as recently as in
The New York Review in 2010) that you can strip insurance profits out of the equation, as with
Medicare, and yet the costs, fraud, etc., of fee-for-service would still spiral
up.
But, obversely, if all physicians worked in collaborative groups and within global
payment, and even if all insurers were private, we would still be substantially
better off. Relman does not say this, but he implies it by speaking of a “transformation”
through expansion of multispecialty doctor cooperatives. Starr,
Atul Gawande,
and others anticipate just such gains from physicians working within the Act,
buttressed by increasing leverage from Medicare to induce global payment based
on best practice. Curiously, Relman dismisses as “marginal” other inferences to
be drawn from his diagnosis (e.g., that advances in information technology,
wedded to common reporting standards, could at least lower claims-processing
costs). He dismisses, that is, my admiration. So be it.
Relman
and the other letter writers are shrewd to identify the for-profit insurance industry
as a defender of fee-for-service. But, surely, its defenders are not just insurance
companies. Relman has argued himself, also shrewdly, that “economic incentives
for health care providers, particularly physicians,” is the second side of the
patient-provider-insurance triangle. Starr shows that AMA opposition has been
at least as important as insurance (and drug) company lobbying in taking
single-payer off the Congress’s table at least since Carter. Oh, and then there
is the third side, the patients, unions—a majority of voters in the last
election, actually—who like their care and don’t want change.
Incidentally,
Relman conflates the added costs of “billing and collecting” from multiple
providers with the added costs of insurance profit. The latter adds about 4% to
every private insurance policy (and a certain stability to our pension funds,
but never mind). According to
the CBO, complex claims-processing has
historically added at least twice that amount; Himmelstein and Woolhandler
suggest $400 billion and, unlike Relman, seem not to consider this problem
marginal. I claimed (after Dr. Ezekiel Emmanuel) that processing costs could be
substantially reduced to levels more like those of processing credit card
charges; I added that, ironically, it is the for-profit insurance companies that
have the greatest “commercialized” incentive to reduce processing costs,
precisely to protect their 4%. Himmelstein and Woolhandler insist that, no,
reporting standards are already ubiquitous and that the claims of savings from
information technology have been empty for 46 years. Uwe Reinhardt’s research would contradict
their view of standards. If they think information technology has not improved
since 1966, they are not, let us say, paying attention.
I
don’t know what Peter Shapiro means by the insurance industry “pricing itself
out of the market.” Patients do not buy health insurance the way we buy, say, vacations.
Nor does the Act require providers and insurers to be for-profit; again, nothing
now prevents non-profit multispecialty cooperatives from starting up and
growing. I cannot deal fully here with Shapiro’s claim that, based on
Massachusetts, medical bankruptcies will be as numerous under the Act as before.
I read
the report he refers to. The causes of personal bankruptcies are not as
clear as Shapiro makes out. Nor does the claim stand the test of common sense,
given the new protections against denial of coverage, for portability, and
subsidies for people who cannot afford insurance (in Massachusetts, my son and
his wife among them, for a while).
Dr. Wood is understandably frustrated writing letters to advocate for his patients. But even not-for-profit health insurance companies, as in Switzerland, or non-profit sick funds as in Israel, have formularies and best practice conventions which
may be debatable. I can assure you that Israeli physicians also have to write
letters of protest or finesse the system. It is nonsense to say that insurance
“profits and dividends” make the US system so expensive. I can’t speak to why
specific protesters in favor of single-payer were denied access to a Senate hearing.
I can say that elaborate proposals, including the 2003 one in
JAMA by
Drs. , Himmelstein, Woolhandler, and Marcia Angell have been heard in
Democratic Party circles for a generation.
Of course progressives should not be silent about healthcare, education, or anything else. But speaking carries the responsibility of political sense. Shall
we also say that Obama’s effort to increase subsidized student loans is a give-away to the private education industry? Ontario has highly subsidized universities, too. Alas, taking to the streets (or writing a book review or letter) is a lot easier than running for office and getting legislation passed.
America has a politics that requires Democrats to swim perpetually against the current. The miracle of Obamacare, and the Obama presidency, is that we’ve lived to see them. We could lose them both.